Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement (Q37836900)

24 August 2017

1 reference

title

Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement (English)

1 reference

24 August 2017

1 reference

1 reference

Filippo Ansaldi

1 reference

24 August 2017

Giancarlo Icardi

1 reference

24 August 2017

Paolo Durando

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

24 August 2017

March 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21299438

full work available at URL

23 November 2024

http://www.informapharmascience.com/doi/abs/10.1517/14712598.2011.557658

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21299438

http://www.tandfonline.com/doi/pdf/10.1517/14712598.2011.557658

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Expert Opinion on Biological Therapy

23 November 2024

published in

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

415-427

1 reference

Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Antibody response to influenza vaccination in the elderly: a quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

21 January 2018

Safety of MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Immunization with Asian-strain influenza vaccine: equivalence of the subcutaneous and intradermal routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

The response of infants and children to Asian influenza vaccine administered by intradermal and subcutaneous routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

The Immunizing Effect of Influenza A/New Jersey/76 (Hsw1N1) Virus Vaccine Administered Intradermally and Intramuscularly to Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Comparison of Responses to Influenza A/New Jersey /76-A/Victoria/75 Virus Vaccine Administered Intradermally or Subcutaneously to Adults with Chronic Respiratory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Antibody responses after dose-sparing intradermal influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Intradermal vaccine delivery: will new delivery systems transform vaccine administration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Dissolving polymer microneedle patches for influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Improved influenza vaccination in the skin using vaccine coated microneedles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

The cutaneous citadel: a holistic view of skin and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Low-dose intradermal and intramuscular vaccination against hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

Immunogenicity and Safety of an Intradermal Boosting Strategy for Vaccination Against Influenza in Lung Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.557658

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Morbidity and Mortality Weekly Report

23 November 2024

RR8

Centers for Disease Control and Prevention

publication date

2010

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Cochrane Database of Systematic Reviews

23 November 2024

series ordinal

author name string

Demicheli V

publication date

2004

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad in elderly subjects

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Comparison of three different influenza vaccines in institutionalised elderly

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Canada communicable disease report

23 November 2024

2001

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Immunologic reactions following the intradermal inoculation of influenza A and B vaccine.

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

[Subcutaneous and intradermal vaccination with Asian influenza vaccine]

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

The New England Journal of Medicine

23 November 2024

1076

McElroy JT

1969

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Purified Influenza Vaccine: Clinical and Serologic Responses to Varying Doses and Different Routes of Immunization

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

The American Review of Respiratory Disease

23 November 2024

103

579

Marks MI

1971

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Dose sparing with intradermal injection of influenza vaccine

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

The immunogenicity of intradermal influenza vaccination in COPD patients

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Influenza vaccine shortage hits the USA

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Bulletin of the World Health Organization

23 November 2024

693

Briggs DJ

2000

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Serum antibody responses after intradermal vaccination against influenza

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination

23 November 2024

1 reference

https://api.crossref.org/works/10.1517/14712598.2011.557658

23 November 2024

Identifiers

1 reference

24 August 2017

1 reference